CDX General discussion 2024, page-479

Company in a substantial working capital squeeze in my view. They need to pay for manufacturing before product sold and need to build distribution ie sales, marketing and support. This takes time and needs to be funded. Engineering tends to always be an ongoing cost as not easy getting great people back so coys tend to keep them.

Meanwhile, per MST's research, they suggest there is next to nil working capital demands and no need for new equity, even for staff!!! Market smells the problem hence why the share price is where it is IMO. They just refreshed the placement capacity ... so when's the next dilutive raise coming?!